Private Advisor Group’s CRISPR Therapeutics CRSP Stock Holding History

Private Advisor Group’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.07M	Sell	106,662 -597	-0.6%	-$31.5K	0.02%	641
2025 Q4	$5.62M	Sell	107,259 -10,854	-9%	-$650K	0.03%	579
2025 Q3	$7.65M	Buy	118,113 +6,164	+6%	+$354K	0.04%	466
2025 Q2	$5.45M	Buy	111,949 +3,531	+3%	+$137K	0.03%	549
2025 Q1	$3.69M	Buy	108,418 +23,382	+27%	+$991K	0.02%	641
2024 Q4	$3.35M	Buy	85,036 +13,289	+19%	+$628K	0.02%	666
2024 Q3	$3.37M	Sell	71,747 -5,880	-8%	-$298K	0.02%	656
2024 Q2	$4.19M	Buy	77,627 +64,076	+473%	+$3.71M	0.03%	550
2024 Q1	$923K	Buy	13,551 +4,625	+52%	+$331K	0.01%	1191
2023 Q4	$559K	Buy	8,926 +3,272	+58%	+$181K	﹤0.01%	1392
2023 Q3	$254K	Buy	5,654 +618	+12%	+$31.9K	﹤0.01%	1739
2023 Q2	$283K	Buy	5,036 +59	+1%	+$3.35K	﹤0.01%	1665
2023 Q1	$225K	Buy	+4,977	New	+$242K	﹤0.01%	1729
2022 Q4	–	Sell	-6,235	Closed	-$407K	–	1720
2022 Q3	$407K	Buy	6,235 +151	+2%	+$10.9K	﹤0.01%	1337
2022 Q2	$370K	Sell	6,084 -358	-6%	-$21K	﹤0.01%	1545
2022 Q1	$404K	Sell	6,442 -5,015	-44%	-$315K	﹤0.01%	1524
2021 Q4	$868K	Sell	11,457 -1,485	-11%	-$130K	0.01%	1189
2021 Q3	$1.45M	Buy	12,942 +3,083	+31%	+$387K	0.01%	1032
2021 Q2	$1.6M	Sell	9,859 -545	-5%	-$66.3K	0.01%	843
2021 Q1	$1.27M	Buy	10,404 +2,572	+33%	+$388K	0.01%	898
2020 Q4	$1.2M	Buy	7,832 +3,346	+75%	+$395K	0.01%	829
2020 Q3	$375K	Sell	4,486 -721	-14%	-$64K	﹤0.01%	1169
2020 Q2	$383K	Buy	5,207 +340	+7%	+$19.9K	0.01%	1115
2020 Q1	$206K	Sell	4,867 -2,832	-37%	-$146K	﹤0.01%	1218
2019 Q4	$469K	Buy	+7,699	New	+$420K	0.01%	1068
2019 Q3	–	Sell	-4,352	Closed	-$205K	–	1681
2019 Q2	$205K	Buy	+4,352	New	+$174K	﹤0.01%	1501
2018 Q4	–	Sell	-8,260	Closed	-$366K	–	1395
2018 Q3	$366K	Buy	8,260 +4,485	+119%	+$235K	0.01%	1131
2018 Q2	$227K	Buy	+3,775	New	+$215K	﹤0.01%	1126